Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time

21 Jan 2015

Abstract excerpt

Defects in antigen presenting cell function have been implicated in glioma immunosuppression. We measured peripheral CCL22, a dendritic cell/macrophage derived T cell trafficking chemokine, in sera from 1,208 glioma cases and 976 controls to assess whether it might provide a biomarker of glioma risk, survival and immune dysfunction. Cluster models were used to examine the relationship between CCL22 and glioma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemokine receptors and signaling
Share to Glioma Diagnosis and Treatment
Share to Immune cells in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25604093
DOI: 10.1002/ijc.29441

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival timePMID 25604093Read ↗

A novel chemokine‐based signature for prediction of prognosis and therapeutic response in gliomaSemantic proximity Read ↗

Impact of beta‐2 microglobulin expression on the survival of glioma patients via modulating the tumor immune microenvironmentSemantic proximity Read ↗

Comprehensive Analysis of CCL21 in Human Tumors:A Potential Therapeutic Target Associated with Immune InfiltrationSemantic proximity Read ↗

Downregulation of CCL22 and Mutation of NOTCH1 in Tongue Squamous Cell Carcinoma Decreases Th2 Cell Recruitment and Expression to Predict Poor Clinical OutcomesSemantic proximity Read ↗

Downregulation of CCL22 and mutated NOTCH1 in tongue and mouth floor squamous cell carcinoma results in decreased Th2 cell recruitment and expression, predicting poor clinical outcome.Semantic proximity Read ↗

SLIT2-ROBO signaling in tumor-associated microglia/macrophages drives glioblastoma immunosuppression and vascular dysmorphiaSemantic proximity Read ↗

Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2 <sup>+</sup> myeloid cells into the tumor microenvironment in a redundant mannerSemantic proximity Read ↗

Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targetingSemantic proximity Read ↗

The MIF promoter SNP rs755622 is associated with immune activation in glioblastoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.